The entries of “Technologies made in Vienna” are displayed in the project language.
Technologies from Vienna
Interventional Oncology - Clinical Service Application Support of Photonic Tumor Therapy
Clinical Service in Interventional OncologyWhy even PDT®
Cancer care currently lacks of efficacy, safety, overall survival, QoL and cost effectiveness.
Company’s unique capacity to solve the problem leaded to Photonic Tumor Therapy and a worldwide IP portfolio of patents and trademarks.
Intensive R&D over ten yrs ended in two non-toxic components - light and oxygen.
Patients’ individually administered, inert photon transformer identifies abnormal cell growth and locates therein temporarily.
Diseases’ individually modulated laser light induces toxic/singlet oxygen - no ROS - killing proliferated cells by apoptosis and necrosis.
Photonic Tumor Therapy is available as CE-certified, hands-on “Clinical Service Application Support”.
Applicable for precursors, developed & metastatic cancers in the biliary system, bladder, bronchus, cardia, cervix uteri, colon, esophagus/Barrett's, lung, pancreas, rectum.
Safe and effective in 400+ applications, extended survival - 700+ yrs up to now - to standard, QoL, no procedure related mortality.
Reimbursed in major markets, flat rate, pay-per-use.
Global roll out under way.
ReferenzkundenMedical University of Vienna, University Hospital, Clinical Department of Internal Medicine III, Gastroenterology & Hepatology
Medical University of Vienna, University Hospital, Clinical Department of Internal Medicine II
Medical University of Graz, University Hospital, Clinical Department of Internal Medicine, Division of Gastroenterology & Hepatology
Kontakt Wirtschaftsagentur Wien
The “Fit for the Future” project is co-financed by the European Regional Development Fund and contributes to the development of applied research and innovation activities in Vienna, promoting cooperation and inspiring young people in Vienna to explore research and innovation. Further information can be found under the IGJ/ERDF funding programme.